Literature DB >> 15201986

Complex p63 mRNA isoform expression patterns in squamous cell carcinoma of the head and neck.

Niklas Thurfjell1, Philip J Coates, Tony Uusitalo, David Mahani, Erik Dabelsteen, Ake Dahlqvist, Björn Sjöström, Göran Roos, Karin Nylander.   

Abstract

The human p63 gene encodes a series of protein isoforms that differ in their N- and/or C-terminal sequences and possess widely varying activities in promoting or repressing p53-related functions and in regulating the proliferation and differentiation of epithelial cells. To gain further information on the role of p63 expression in human tumours, we used quantitative real-time RT-PCR to study individual p63 isoforms in squamous cell carcinomas of the head and neck (SCCHN). In keeping with previous reports, expression of the deltaN- and p63alpha-isoforms predominated and deltaNp63 mRNA was expressed at significantly higher levels in tumours compared to matched normal tissues. Some tumours also expressed the highly efficient transactivator TA- and p63beta-isoforms, and p63beta was significantly increased in tumours compared to matched normal tissue. We could not identify any correlations between different p63-isoform expression patterns and proliferation, p53 status, or telomerase expression. All p63 isoforms could be identified in normal surface epithelium, and micro-dissection showed that the high levels present in basal layers were similar to those seen in tumour tissues. Thus, high-level expression of deltaNp63 in tumour cells may represent maintained expression by the basal cells from which the tumour arose, rather than representing a true over-expression of p63 during tumourigenesis. Tobacco usage, a genotoxic predisposing factor for SCCHN, had no effect on p63 expression in oral epithelium. Taken together, our data indicate that SCCHN maintain expression of high levels of deltaNp63alpha in combination with varying levels of other p63 isoforms, some of which are highly efficient transcriptional activators. The complexity of these p63 expression patterns seen in primary SCCHN indicates that p63 has multifaceted roles in tumour biology.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15201986

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  15 in total

1.  Expression and regulation of the ΔN and TAp63 isoforms in salivary gland tumorigenesis clinical and experimental findings.

Authors:  Yoshitsugu Mitani; Jie Li; Randal S Weber; Scott L Lippman; Elsa R Flores; Carlos Caulin; Adel K El-Naggar
Journal:  Am J Pathol       Date:  2011-05-07       Impact factor: 4.307

2.  Immunohistochemical expression of p63, p53 and MIB-1 in urinary bladder carcinoma. A tissue microarray study of 158 cases.

Authors:  Eva Compérat; Philippe Camparo; Rachel Haus; Emmanuel Chartier-Kastler; Stephane Bart; Annick Delcourt; Alain Houlgatte; Richard François; Fréderique Capron; Annick Vieillefond
Journal:  Virchows Arch       Date:  2005-11-08       Impact factor: 4.064

3.  Characterization of specific p63 and p63-N-terminal isoform antibodies and their application for immunohistochemistry.

Authors:  Marta Nekulova; Jitka Holcakova; Rudolf Nenutil; Rembert Stratmann; Pavla Bouchalova; Petr Müller; Lucie Mouková; Philip J Coates; Borivoj Vojtesek
Journal:  Virchows Arch       Date:  2013-07-26       Impact factor: 4.064

4.  p63 is necessary for the activation of human papillomavirus late viral functions upon epithelial differentiation.

Authors:  Kristen K Mighty; Laimonis A Laimins
Journal:  J Virol       Date:  2011-06-29       Impact factor: 5.103

5.  NRP-1 interacts with GIPC1 and α6/β4-integrins to increase YAP1/∆Np63α-dependent epidermal cancer stem cell survival.

Authors:  Daniel Grun; Gautam Adhikary; Richard L Eckert
Journal:  Oncogene       Date:  2018-05-14       Impact factor: 9.867

6.  DeltaNp63 overexpression, alone and in combination with other biomarkers, predicts the development of oral cancer in patients with leukoplakia.

Authors:  Pierre Saintigny; Adel K El-Naggar; Vali Papadimitrakopoulou; Hening Ren; You-Hong Fan; Lei Feng; J Jack Lee; Edward S Kim; Waun Ki Hong; Scott M Lippman; Li Mao
Journal:  Clin Cancer Res       Date:  2009-09-22       Impact factor: 12.531

7.  Expression pattern of p63 in oral epithelial lesions and submucous fibrosis associated with betel-quid chewing in Sri Lanka.

Authors:  Abusayeed M Haniffa; Masato Saitoh; Yoshihiro Abiko; Maiko Takeshima; Michiko Nishimura; Mami Yamazaki; Hiroki Nagayasu; Chihiro Sugiura; Malantha Muthumala; Tohru Kaku; Itsuo Chiba; Toshiyuki Shibata
Journal:  Med Mol Morphol       Date:  2007-12-21       Impact factor: 2.309

8.  p63 Immunoexpression in lip carcinogenesis.

Authors:  Flávia Caló Aquino Xavier; Christina Maeda Takiya; Sílvia Regina Almeida Reis; Luciana Maria Pedreira Ramalho
Journal:  J Mol Histol       Date:  2009-06-13       Impact factor: 2.611

9.  Expression of p53 isoforms in squamous cell carcinoma of the head and neck.

Authors:  Linda Boldrup; Jean-Christophe Bourdon; Philip J Coates; Björn Sjöström; Karin Nylander
Journal:  Eur J Cancer       Date:  2007-01-09       Impact factor: 9.162

10.  Subsite-based alterations in miR-21, miR-125b, and miR-203 in squamous cell carcinoma of the oral cavity and correlation to important target proteins.

Authors:  Linda Boldrup; Philip J Coates; Magnus Wahlgren; Göran Laurell; Karin Nylander
Journal:  J Carcinog       Date:  2012-11-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.